Wolf P - Search Results

1

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.

Bühler P, Wolf P, Gierschner D, Schaber I, Katzenwadel A, Schultze-Seemann W, Wetterauer U, Tacke M, Swamy M, Schamel WW, Elsässer-Beile U. Bühler P, et al. Among authors: wolf p. Cancer Immunol Immunother. 2008 Jan;57(1):43-52. doi: 10.1007/s00262-007-0348-6. Epub 2007 Jun 20. Cancer Immunol Immunother. 2008. PMID: 17579857 Free PMC article.

2

Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.

Elsässer-Beile U, Leiber C, Wolf P, Lucht M, Mengs U, Wetterauer U. Elsässer-Beile U, et al. Among authors: wolf p. J Urol. 2005 Jul;174(1):76-9. doi: 10.1097/01.ju.0000163261.08619.d0. J Urol. 2005. PMID: 15947582 Clinical Trial.

3

Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.

Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U. Elsässer-Beile U, et al. Among authors: wolf p. Anticancer Res. 2005 Nov-Dec;25(6C):4733-6. Anticancer Res. 2005. PMID: 16334168 Free article. Clinical Trial.

4

A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.

Wolf P, Gierschner D, Bühler P, Wetterauer U, Elsässer-Beile U. Wolf P, et al. Cancer Immunol Immunother. 2006 Nov;55(11):1367-73. doi: 10.1007/s00262-006-0131-0. Epub 2006 Mar 18. Cancer Immunol Immunother. 2006. PMID: 16547705 Free PMC article.

5

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.

Elsässer-Beile U, Wolf P, Gierschner D, Bühler P, Schultze-Seemann W, Wetterauer U. Elsässer-Beile U, et al. Among authors: wolf p. Prostate. 2006 Sep 15;66(13):1359-70. doi: 10.1002/pros.20367. Prostate. 2006. PMID: 16894535

6

Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.

Wolf P, Alt K, Bühler P, Katzenwadel A, Wetterauer U, Tacke M, Elsässer-Beile U. Wolf P, et al. Prostate. 2008 Feb 1;68(2):129-38. doi: 10.1002/pros.20684. Prostate. 2008. PMID: 18044731

7

Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.

Wolf P, Elsässer-Beile U. Wolf P, et al. Int J Med Microbiol. 2009 Mar;299(3):161-76. doi: 10.1016/j.ijmm.2008.08.003. Epub 2008 Oct 23. Int J Med Microbiol. 2009. PMID: 18948059 Review.

8

Targeted therapies for prostate cancer against the prostate specific membrane antigen.

Elsässer-Beile U, Bühler P, Wolf P. Elsässer-Beile U, et al. Among authors: wolf p. Curr Drug Targets. 2009 Feb;10(2):118-25. doi: 10.2174/138945009787354601. Curr Drug Targets. 2009. PMID: 19199907 Review.

9

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

Elsässer-Beile U, Reischl G, Wiehr S, Bühler P, Wolf P, Alt K, Shively J, Judenhofer MS, Machulla HJ, Pichler BJ. Elsässer-Beile U, et al. Among authors: wolf p. J Nucl Med. 2009 Apr;50(4):606-11. doi: 10.2967/jnumed.108.058487. Epub 2009 Mar 16. J Nucl Med. 2009. PMID: 19289418 Free article.

10

Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells.

Liu J, Kopecková P, Bühler P, Wolf P, Pan H, Bauer H, Elsässer-Beile U, Kopecek J. Liu J, et al. Among authors: wolf p. Mol Pharm. 2009 May-Jun;6(3):959-70. doi: 10.1021/mp8002682. Mol Pharm. 2009. PMID: 19344119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,429 results

Search Page

Filters